STAT+: Are AI scribes medical devices? U.K. regulator weighs in
Reported by STAT News · all stories from statnews.com
Editorial digest
A regulatory body in the United Kingdom is examining whether artificial intelligence scribes should be classified as medical devices. This assessment could set important precedents for health technology.
Digests are written in our own words from the publisher's headline — we never reproduce article text. Read the original for the full reporting.
Read the full story at STAT News →More like this
Other stories our editors tagged with the same themes.
- Trusted health newsroom10/14/2026
STAT+: Lobbyists and trade groups fight to shape how states regulate medical AI
Industry representatives are working to influence state-level medical artificial intelligence rules.
- Trusted health newsroom9/3/2026
STAT+: FDA pilot offers generative AI medical devices a path to patients before they are authorized
FDA pilot program allows generative AI devices to reach patients pre-authorization.
- Trusted health newsroom8/20/2026
FDA weighs regulatory approach for genAI medical devices - MobiHealthNews
The FDA is deliberating its regulatory strategy for generative AI medical devices.
- Trusted health newsroom10/15/2026
STAT+: ‘AI sandboxes’ are all the rage. Advocates scramble to control their future
Industry experts are working to influence the development of regulatory frameworks for artificial intelligence innovation zones.
- Reputable trade press8/19/2026
FDA Weighs Clinician-Style Tests for Generative AI Medical Devices - PYMNTS.com
FDA considers clinician-style evaluations for generative AI medical devices.
- Trusted health newsroom10/8/2026
STAT+: AI for breast cancer risk prediction goes DTC, regulatory cloud over Utah sandbox, and AI psychosis
AI for breast cancer risk is now direct-to-consumer; regulatory concerns and AI-induced psychosis are also discussed.